Bio-Techne (TECH) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.14% |
| Dec 31, 2025 | 5.61% |
| Sep 30, 2025 | 6.43% |
| Jun 30, 2025 | 6.80% |
| Mar 31, 2025 | 9.34% |
| Dec 31, 2024 | 9.45% |
| Sep 30, 2024 | 12.74% |
| Jun 30, 2024 | 12.16% |
| Mar 31, 2024 | 11.94% |
| Dec 31, 2023 | 12.36% |
| Sep 30, 2023 | 12.48% |
| Jun 30, 2023 | 12.75% |
| Mar 31, 2023 | 12.29% |
| Dec 31, 2022 | 12.86% |
| Sep 30, 2022 | 12.77% |
| Jun 30, 2022 | 12.36% |
| Mar 31, 2022 | 13.54% |
| Dec 31, 2021 | 13.84% |
| Sep 30, 2021 | 12.96% |
| Jun 30, 2021 | 12.31% |
| Mar 31, 2021 | 12.66% |
| Dec 31, 2020 | 12.32% |
| Sep 30, 2020 | 11.43% |
| Jun 30, 2020 | 10.28% |
| Mar 31, 2020 | 9.50% |
| Dec 31, 2019 | 10.03% |
| Sep 30, 2019 | 8.16% |
| Jun 30, 2019 | 7.95% |
| Mar 31, 2019 | 8.09% |
| Dec 31, 2018 | 7.93% |
| Sep 30, 2018 | 8.83% |
| Jun 30, 2018 | 7.91% |
| Mar 31, 2018 | 8.02% |
| Dec 31, 2017 | 7.51% |
| Sep 30, 2017 | 7.12% |
| Jun 30, 2017 | 7.08% |
| Mar 31, 2017 | 7.09% |
| Dec 31, 2016 | 8.31% |
| Sep 30, 2016 | 8.72% |
| Jun 30, 2016 | 8.45% |
| Mar 31, 2016 | 8.54% |
| Dec 31, 2015 | 9.58% |
| Sep 30, 2015 | 9.86% |
| Jun 30, 2015 | 11.04% |
| Jun 30, 2014 | 11.74% |